GC BIOPHARMA
LIVE

Serial Number

97298515

Owner

Green Cross Holdings Corporation

Attorney

Kwang Yup Chae

First Use Date

Mar 29, 2022

Filing Date

Mar 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GC BIOPHARMA Trademark

Serial Number: 97298515 • Registration: 8152205

GC BIOPHARMA is a trademark filed by Green Cross Holdings Corporation on March 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Green Cross Holdings Corporation (24 trademarks)

107, Ihyeon-ro 30beon-gil, Giheung-gu,
Yongin-si, Gyeonggi-do 16924 , KR

Entity Type: 03

Trademark Details

Filing Date

March 7, 2022

Registration Date

February 24, 2026

First Use Anywhere

March 29, 2022

First Use in Commerce

July 8, 2024

Published for Opposition

December 13, 2022

Goods & Services

Medicines for humans used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors

Research and development of medicines; Research and development, scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Scientific research in the fields of biomedicine; Research and development in the pharmaceutical and biotechnology fields

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 24, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 5, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 5, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2026 CRFA
ASSIGNED TO LIE
Feb 5, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 14, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 10, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 10, 2025 AITU
USE AMENDMENT FILED
May 8, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 8, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 5, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 5, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jul 22, 2024 EX3G
SOU EXTENSION 3 FILED
Jul 22, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 22, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jan 17, 2024 EX2G
SOU EXTENSION 2 FILED
Jan 17, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 16, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 16, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 16, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 4, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 4, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 4, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 4, 2022 CNEA
ASSIGNED TO EXAMINER
Oct 28, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 12, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2022 NWOS
NEW APPLICATION ENTERED
Mar 10, 2022 NWAP